A17T (p.Ala17Thr) variant of SOST (Sclerostin)
A17T (p.Ala17Thr) in SOST (Sclerostin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
A17T (p.Ala17Thr) variant details
- p.Ala17Thr
- NCI-TCGA Cosmic COSV1000
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available